Systemic Elevation of PTEN Induces a Tumor-Suppressive Metabolic State

被引:323
作者
Garcia-Cao, Isabel [1 ,2 ]
Song, Min Sup [1 ,2 ]
Hobbs, Robin M. [1 ,2 ]
Laurent, Gaelle [3 ]
Giorgi, Carlotta [4 ,5 ]
de Boer, Vincent C. J. [3 ]
Anastasiou, Dimitrios [6 ]
Ito, Keisuke [1 ,2 ]
Sasaki, Atsuo T. [6 ]
Rameh, Lucia [7 ]
Carracedo, Arkaitz [1 ,2 ]
Vander Heiden, Matthew G. [8 ]
Cantley, Lewis C. [6 ]
Pinton, Paolo [4 ,5 ]
Haigis, Marcia C. [3 ]
Pandolfi, Pier Paolo [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Med Ctr, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Cell Biol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA
[4] Univ Ferrara, ICSI, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy
[5] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy
[6] Harvard Univ, Sch Med, Dept Syst Biol,Beth Israel Deaconess Med Ctr, Dept Med,Div Signal Transduct, Boston, MA 02115 USA
[7] Boston Biomed Res Inst, Watertown, MA 02472 USA
[8] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
关键词
DNA-DAMAGE RESPONSE; C-MYC; CELL-SIZE; SIGNALING PATHWAY; PYRUVATE-KINASE; PHOSPHOINOSITIDE; 3-KINASE; CANCER SUSCEPTIBILITY; GROWTH; DROSOPHILA; EXPRESSION;
D O I
10.1016/j.cell.2012.02.030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Decremental loss of PTEN results in cancer susceptibility and tumor progression. PTEN elevation might therefore be an attractive option for cancer prevention and therapy. We have generated several transgenic mouse lines with PTEN expression elevated to varying levels by taking advantage of bacterial artificial chromosome (BAC)-mediated transgenesis. The "Super-PTEN" mutants are viable and show reduced body size due to decreased cell number, with no effect on cell size. Unexpectedly, PTEN elevation at the organism level results in healthy metabolism characterized by increased energy expenditure and reduced body fat accumulation. Cells derived from these mice show reduced glucose and glutamine uptake and increased mitochondrial oxidative phosphorylation and are resistant to oncogenic transformation. Mechanistically we find that PTEN elevation orchestrates this metabolic switch by regulating PI3K-dependent and -independent pathways and negatively impacting two of the most pronounced metabolic features of tumor cells: glutaminolysis and the Warburg effect.
引用
收藏
页码:49 / 62
页数:14
相关论文
共 75 条
[51]   Cell biology - Chewing the fat - ACC and energy balance [J].
Ruderman, N ;
Flier, JS .
SCIENCE, 2001, 291 (5513) :2558-2559
[52]   Tenets of PTEN tumor suppression [J].
Salmena, Leonardo ;
Carracedo, Arkaitz ;
Pandolfi, Pier Paolo .
CELL, 2008, 133 (03) :403-414
[53]   The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila [J].
Scanga, SE ;
Ruel, L ;
Binari, RC ;
Snow, B ;
Stambolic, V ;
Bouchard, D ;
Peters, M ;
Calvieri, B ;
Mak, TW ;
Woodgett, JR ;
Manoukian, AS .
ONCOGENE, 2000, 19 (35) :3971-3977
[54]   Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability [J].
Sears, R ;
Nuckolls, F ;
Haura, E ;
Taya, Y ;
Tamai, K ;
Nevins, JR .
GENES & DEVELOPMENT, 2000, 14 (19) :2501-2514
[55]   PTEN: Life as a tumor suppressor [J].
Simpson, L ;
Parsons, R .
EXPERIMENTAL CELL RESEARCH, 2001, 264 (01) :29-41
[56]   Nuclear PTEN Regulates the APC-CDH1 Tumor-Suppressive Complex in a Phosphatase-Independent Manner [J].
Song, Min Sup ;
Carracedo, Arkaitz ;
Salmena, Leonardo ;
Song, Su Jung ;
Egia, Ainara ;
Malumbres, Marcos ;
Pandolfi, Pier Paolo .
CELL, 2011, 144 (02) :187-199
[57]   High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice [J].
Suzuki, A ;
de la Pompa, JL ;
Stambolic, V ;
Elia, AJ ;
Sasaki, T ;
Barrantes, ID ;
Ho, A ;
Wakeham, A ;
Itie, A ;
Khoo, W ;
Fukumoto, M ;
Mak, TW .
CURRENT BIOLOGY, 1998, 8 (21) :1169-1178
[58]   mTOR, translational control and human disease [J].
Tee, AR ;
Blenis, J .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (01) :29-37
[59]   Ras transformation requires metabolic control by 6-phosphofructo-2-kinase [J].
Telang, S. ;
Yalcin, A. ;
Clem, A. L. ;
Bucala, R. ;
Lane, A. N. ;
Eaton, J. W. ;
Chesney, J. .
ONCOGENE, 2006, 25 (55) :7225-7234
[60]   Targeting metabolic transformation for cancer therapy [J].
Tennant, Daniel A. ;
Duran, Raul V. ;
Gottlieb, Eyal .
NATURE REVIEWS CANCER, 2010, 10 (04) :267-277